Research & Development
Academic Report
【Conference presentation】Development of biomarkers to predict response of immune checkpoint inhibitors in lung cancer
| Presented by: | Kanako Sakaeda1), Koji Kurose2), Minoru Fukuda3), Takashi Kitazaki4), Masaak Fukudai4), Nanae Sugasaki5), Akitoshi Kinoshita5), Takeshi Masuda6), Noboru Hattori6), Shinnosuke Takemoto3), Hiroyuki Yamaguchi3), Yusuke Atarashi7), Yumiko Sakai1), Yasuhiro Irino1), Mami Yamaki8), Toshiyuki Sato1), Hiroshi Mukae3), Toru Oga2), Mikio Oka9) 1) Central Research Laboratories, Sysmex Corporation 2) Department of Respiratory Medicine, Kawasaki Medical School 3) Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences 4) The Japanese Red Cross Nagasaki Genbaku Hospital 5) Nagasaki Prefectural Shimabara Hospital 6) Department of Respiratory Medicine, Hiroshima University Hospital 7) Bio-Diagnostic Reagent Technology Center, Sysmex Corporation 8）Business Strategy Development, Sysmex Corporation 9）Immuno-Oncology, Kawasaki Medical School |
| Academic conference: | The 26th Annual Meeting of Japanese Association of Cancer Immunology |
| Presentation Date: | July 20, 2022 |
- Information contained in the academic report is current as of the date of the announcement,
but may be subject to change without prior notice.